Landis+Gyr Announces Second Quarter and First Half FY 2026 Financial Results

Landis+Gyr reported first-half FY2026 revenue of $501.4 million, down 6.3% year over year, while adjusted EBITDA rose 3.5% to $73.9 million and adjusted gross margin expanded 370 basis points to 37.7%. The company narrowed FY2026 revenue guidance to $1,085–$1,115 million and raised adjusted EBITDA margin guidance to 15.0%–16.0%, citing an expected strong second half. It also completed $175 million of share repurchases and disclosed a $509 million order intake from a major contract awarded after the half-year close.

Analysis

The key debate is whether margin gains reflect durable operating leverage or favorable deployment mix during a temporary revenue trough. If the new customer ramps arrive on schedule, fixed-cost absorption could support the higher EBITDA-margin outlook; if timing slips, a low first-half book-to-bill and dependence on a large post-period award leave less evidence of broad-based demand than the backlog headline implies. Backlog is not revenue until deployment milestones, acceptance, and customer schedules convert it.

Near term, the raised margin outlook and completed capital return are supportive, but the $175 million repurchase is not a substitute for organic order replenishment. Over the next 1–3 months, deployment commentary and order intake will matter more than the headline margin: monitor whether new awards diversify demand or reinforce customer/project concentration. Over 6–18 months, a U.S. listing could widen the investor pool and improve trading access, but any valuation benefit is conditional on execution and should not be assumed before listing details and costs are clear.

The contrarian risk is that investors treat the award and margin guidance as confirmation of a broad smart-grid acceleration, while the order cadence may remain lumpy. Itron is a useful peer read-through, not a direct hedge: contract mix and execution differ. The thesis weakens if guidance is cut, deployments slip, or subsequent order intake fails to rebuild coverage; it strengthens if revenue conversion and margins improve together without renewed reliance on large one-off awards.

Key Decisions for Investors

• No chase on the announcement alone. Consider a modest LAND position only if the next update confirms customer deployments are converting into revenue and supports the raised margin range; define risk around a guidance reduction or disclosed deployment delay.
• Track quarterly order intake, cancellations, backlog conversion, and customer concentration. Treat the October award as a positive catalyst, but verify contract timing and scope before using it to infer a sustained demand recovery.
• Use Itron as a relative operating read-through, not an automatic pair-trade short: compare order trends, deployment timing, and margin progression before expressing a LAND-versus-peer view.
• For the U.S. listing catalyst, wait for specific timing, structure, and incremental cost disclosures. Reassess only if improved liquidity or investor access appears likely to outweigh execution and listing expenses.